Taro to Acquire Alchemee from Galderma

Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care

Galderma and Taro Pharmaceutical Industries announced today they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from Galderma.

The agreement between Galderma and Taro includes Alchemee's business and assets around the world, including the Proactiv@ brand. 'We are excited to add Proactivto Taro's broad portfolio of prescription and over-the-counter dermatology products. We look forward to welcoming the Alchemee team into Taro and working together to continue to make a difference to the millions of people living with acne around the world said, Uday Baldota, CEO Taro.

Proactiv@has been used and trusted by millions around the world for more than 25 years. Originally set up as a subscription-based business, Proactiv@quickly became a leading U.S. consumer acne brand. "We are proud of the work we have done together to serve customers suffering from acne around the world through Proactiv. I am confident that Taro is the right owner to build on Alchemee's strong foundation. Their vision is aligned to Alchemee which comes with an incredible legacy and brand equity, and a great team with a clear plan for future success." Flemming Ornskov. CEO Galderma. The acquisition is subject to customary closing conditions and any necessary regulatory approvals.